Epsilon Healthcare Limited (HDRPF)
Epsilon Healthcare Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Southport, QLD, AU. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $3.9M. On trailing twelve-month figures it carries a trailing P/E of -8.80, a net margin of -7.1%. Its beta of 0.77 implies it has historically moved less than the broad market.
Epsilon Healthcare Limited functions as a health and pharmaceuticals enterprise with core operations spanning Australia and Canada. The company's activities encompass the manufacturing and supply of hydroponic equipment, materials, and specialized nutrient solutions. Furthermore, it focuses on the development and distribution of medicinal cannabis products, alongside providing comprehensive, turnkey cultivation systems for the plant. Established in 2016, the firm is headquartered in Sydney, Australia. Epsilon Healthcare Limited adopted its current identity in February 2021, having previously been known as THC Global Group Limited.
Epsilon Healthcare Limited is most often compared with the following Healthcare names: